Cargando…
The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema
Angioedema of the upper airways is a severe and potentially life-threatening condition. The incidence has been increasing in the past two decades, primarily due to pharmaceuticals influencing the generation or degradation of the vasoactive molecule bradykinin. Plasma-derived C1-esterase inhibitor co...
Autores principales: | Hermanrud, Thorbjørn, Duus, Nicolaj, Bygum, Anette, Rasmussen, Eva Rye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830721/ https://www.ncbi.nlm.nih.gov/pubmed/27123347 http://dx.doi.org/10.1155/2016/3930923 |
Ejemplares similares
-
Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches
por: Ali, Haivin Aziz, et al.
Publicado: (2019) -
Correction: Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches
por: Ali, Haivin Aziz, et al.
Publicado: (2019) -
Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert®): about one case and review of the therapeutic arsenal
por: Lipski, Samuel Michael, et al.
Publicado: (2015) -
Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema
por: Rasmussen, Eva Rye, et al.
Publicado: (2017) -
Corrigendum to “Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema”
por: Rasmussen, Eva Rye, et al.
Publicado: (2018)